hydrochlorothiazide has been researched along with candesartan cilexetil in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (19.05) | 18.2507 |
| 2000's | 20 (47.62) | 29.6817 |
| 2010's | 12 (28.57) | 24.3611 |
| 2020's | 2 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ito, K; Kito, G; Shiomi, M | 1 |
| Inada, Y; Kanagawa, R; Nishikawa, K; Ojima, M; Sanada, T; Wada, T | 1 |
| Högemann, A; Jonkman, JH; Lins, R; Sennewald, R; van Heiningen, PN; van Lier, JJ | 1 |
| Plouin, PF | 1 |
| Arens, HJ; Letzel, H; Philipp, T | 1 |
| Sever, PS | 1 |
| Cushing, DJ; Gradman, AH; Hardison, JD; Jones, DW; Levine, JH; Michelson, EL; Oparil, S; Prasad, R; Ripley, E; Zuschke, CA | 1 |
| Oparil, S | 1 |
| Istad, H; Keinänen-Kiukaanniemi, S; McInnes, GT; O'Kane, KP; Van Mierlo, HF | 1 |
| Dahl, M; Kahan, T; Malmqvist, K | 1 |
| Antonios, TF; He, FJ; MacGregor, GA; Viskoper, JR | 1 |
| Milon, H; Ohma, KP; Valnes, K | 1 |
| Ruilope, L | 1 |
| Forsén, B; Neldam, S | 1 |
| Campbell, M; Sonkodi, S; Soucek, M; Wiecek, A | 1 |
| Jarvis, B; Melian, EB | 1 |
| Abellán, J; de Castro, SS; De Vinuesa, SG; Fernández-Vega, F; Luño, J; Maceira, B; Nicolás, RR; Rodríguez, JC; Vegazo, O | 1 |
| Erk, N | 1 |
| Cook, AK; Imig, JD; Inscho, EW; Murzynowski, JB | 1 |
| Bönner, G; Fuchs, W | 1 |
| Braun, M; Funken, C; Gerwe, M; Weisser, B | 1 |
| Fimmers, R; Mengden, T; Uen, S; Un, I; Vetter, H | 1 |
| Derosa, G; Fogari, R; Mugellini, A | 1 |
| Bramlage, P; Funken, C; Odoj, P; Schönrock, E; Wolf, WP | 1 |
| Edes, I | 1 |
| Asmar, R; Baguet, JP; Mallion, JM; Nisse-Durgeat, S; Valensi, P | 1 |
| Kusumoto, K; Mori, M; Tanokashira, J; Totsuka, N | 1 |
| Bramlage, P; Mengden, T; Uen, S | 1 |
| Bramlage, P; Ketelhut, R | 1 |
| Bönner, G; Bramlage, P; Landers, B | 1 |
| Ahn, YK; Choi, D; Chung, WJ; Hong, BK; Jeon, DW; Jung, HO; Kim, BO; Kim, D; Kim, SH; Lee, BK; Lee, HY; Lee, SH; Park, CK | 1 |
| Aberg, JG; Karlson, BW; Olofsson, B | 1 |
| Riem, L | 1 |
| Bharathi, DV; Chatki, PK; Hotha, KK; Satyanarayana, V; Venkateswarlu, V | 1 |
| Mugellini, A; Nieswandt, V | 1 |
| Pohan, T; Setiawati, A | 1 |
| Bramlage, P; Buhck, H; Zemmrich, C | 1 |
| de Diego, M; Godoy, R; Mennickent, S; Miranda, D; Navarro, P; Vergara, C | 1 |
| Abdelsalam, RA; Haddad, GM; Marghany, KA | 1 |
| Diaz, L; Feleder, EC; Haddad, T; Halabe, EK; Iglesias, M; Mondelo, N; Roldán, E; Sakson, M; Yerino, GA | 1 |
5 review(s) available for hydrochlorothiazide and candesartan cilexetil
| Article | Year |
|---|---|
Improving prognosis in hypertension: exploring the benefits of angiotensin II type 1 receptor blockade.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Prognosis; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles | 2000 |
Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diuretics; Drug Evaluation; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Tetrazoles | 2002 |
[Pharmacological and clinical properties of ECARD combination tablets LD & HD, fixed-dose combination of candesartan cilexetil and hydrochlorothiazide].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Drug Combinations; Drug Design; Humans; Hydrochlorothiazide; Hypertension; Rabbits; Rats; Sodium Chloride Symporter Inhibitors; Tablets; Tetrazoles | 2009 |
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cost-Benefit Analysis; Diuretics; Drug Combinations; Drug Costs; Guideline Adherence; Humans; Hydrochlorothiazide; Hypertension; Medication Adherence; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tetrazoles; Treatment Outcome | 2009 |
Candesartan plus hydrochlorothiazide: an overview of its use and efficacy.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Practice Guidelines as Topic; Sodium Chloride Symporter Inhibitors; Tetrazoles | 2012 |
21 trial(s) available for hydrochlorothiazide and candesartan cilexetil
| Article | Year |
|---|---|
Pharmacokinetic drug interaction studies with candesartan cilexetil.
Topics: Adolescent; Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Digoxin; Drug Interactions; Female; Glyburide; Humans; Hydrochlorothiazide; Male; Middle Aged; Nifedipine; Tetrazoles; Warfarin | 1997 |
Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide.
Topics: Adolescent; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Tetrazoles | 1997 |
Dose-finding study of candesartan cilexetil plus hydrochlorothiazide in patients with mild to moderate hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Tetrazoles | 1997 |
Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.
Topics: Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diuretics; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Least-Squares Analysis; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Tetrazoles; Treatment Outcome | 1999 |
Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Demography; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sex Factors; Tetrazoles; Treatment Outcome | 1999 |
Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Treatment Outcome | 2000 |
Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diuretics; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Quality of Life; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium Chloride Symporter Inhibitors; Tetrazoles | 2000 |
Efficacy of candesartan cilexetil alone or in combination with amlodipine and hydrochlorothiazide in moderate-to-severe hypertension. UK and Israel Candesartan Investigators.
Topics: Aldosterone; Amlodipine; Analysis of Variance; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Israel; Male; Middle Aged; Renin; Single-Blind Method; Tetrazoles; United Kingdom | 2000 |
Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 2000 |
Antihypertensive treatment in elderly patients aged 75 years or over: a 24-week study of the tolerability of candesartan cilexetil in relation to hydrochlorothiazide.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Tetrazoles | 2001 |
A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapy.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Placebos; Tablets; Tetrazoles | 2001 |
Angiotensin II type 1 receptor blockade to control blood pressure in postmenopausal women: influence of hormone replacement therapy.
Topics: Age Factors; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diuretics; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Postmenopause; Prospective Studies; Spain; Tetrazoles; Time Factors; Treatment Outcome | 2002 |
Fixed combination of candesartan with hydrochlorothiazide in patients with severe primary hypertension.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2004 |
[Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles | 2005 |
Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Diuretics; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2007 |
Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Primary Health Care; Tetrazoles; Treatment Outcome; Young Adult | 2009 |
Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Carotid Artery Diseases; Carotid Artery, Common; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Progression; Diuretics; Double-Blind Method; Female; France; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Time Factors; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography | 2009 |
Candesartan cilexetil/hydrochlorothiazide treatment in high-risk patients with type 2 diabetes mellitus and microalbuminuria: the CHILI T2D study.
Topics: Aged; Albuminuria; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Risk Factors; Tetrazoles | 2010 |
Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Asian People; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dizziness; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Republic of Korea; Tetrazoles; Treatment Outcome; Young Adult | 2011 |
Pharmacokinetic interaction study with fixed high dose combinations of candesartan cilexetil and hydrochlorothiazide.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Diuretics; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Tetrazoles | 2011 |
Pharmacokinetics of a new fixed-dose combination of candesartan cilexetil, hydrochlorothiazide, and rosuvastatin in healthy adult subjects.
Topics: Adult; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Drug Combinations; Healthy Volunteers; Humans; Hydrochlorothiazide; Rosuvastatin Calcium; Tablets; Tetrazoles; Therapeutic Equivalency | 2022 |
16 other study(ies) available for hydrochlorothiazide and candesartan cilexetil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl] methyl]-1 H-benzimidazole-7-carboxylate. Part II: Effect on cardiovascular system a
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diuretics; Dogs; Guinea Pigs; Heart Rate; Hemodynamics; Hydrochlorothiazide; In Vitro Techniques; Kidney; Male; Potassium; Rats; Rats, Inbred Strains; Regional Blood Flow; Respiratory Mechanics; Sodium; Sodium Chloride Symporter Inhibitors; Tetrazoles; Urodynamics | 1996 |
Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Hydrochlorothiazide; Male; Nitrobenzenes; Piperazines; Prazosin; Rats; Rats, Inbred SHR; Renin; Sodium Chloride Symporter Inhibitors; Tetrazoles | 1996 |
Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Delayed-Action Preparations; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Losartan; Renin-Angiotensin System; Retrospective Studies; Sodium Chloride Symporter Inhibitors; Tetrazoles; Treatment Outcome | 1999 |
Application of first derivative UV-spectrophotometry and ratio derivative spectrophotometry for the simultaneous determination of candesartan cilexetil and hydrochlorothiazide.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calibration; Diuretics; Hydrochlorothiazide; Indicators and Reagents; Sodium Chloride Symporter Inhibitors; Spectrophotometry, Ultraviolet; Tablets; Tetrazoles | 2003 |
Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Drug Therapy, Combination; Homeostasis; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reserpine; Tetrazoles; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2004 |
[Effect of candesartan cilexetil with hydrochlorothiazide on blood pressure and ST-segment depression in patients with arterial hypertension].
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2007 |
[Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with Candesartan/HCTZ].
Topics: Aged; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Risk Factors; Tetrazoles; Treatment Outcome | 2008 |
Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Diuretics; Drug Combinations; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome | 2011 |
[EFFECTIVE data. New effectiveness dimensions in antihypertensive combination therapy].
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Prospective Studies; Tetrazoles | 2011 |
[Focus on compliance. Rapid goal attainment in hypertension].
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Medication Adherence; Tetrazoles | 2011 |
LC-MS/MS method for simultaneous estimation of candesartan and hydrochlorothiazide in human plasma and its use in clinical pharmacokinetics.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Humans; Hydrochlorothiazide; Liquid-Liquid Extraction; Statistics, Nonparametric; Tandem Mass Spectrometry; Tetrazoles | 2012 |
Safety and effectiveness of candesartan and candesartan/HCT fixed dose combination in patients with hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Chest Pain; Diuretics; Drug Combinations; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Nausea; Paresthesia; Prospective Studies; Tetrazoles | 2013 |
Candesartan cilexetil 32 mg/hydrochlorothiazide 25 mg in unselected patients with high or very high cardiovascular risk: efficacy, safety, and metabolic impact.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol; Creatinine; Drug Combinations; Female; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Male; Middle Aged; Potassium; Risk Factors; Tetrazoles; Triglycerides | 2014 |
Stability-Indicating Liquid Chromatographic Methods with Photodiode Array Detection and Light Scattering Detection for Simultaneous Determination of Candesartan and Hydrochlorothiazide.
Topics: Benzimidazoles; Biphenyl Compounds; Chromatography, Liquid; Drug Stability; Hydrochlorothiazide; Limit of Detection; Linear Models; Oxidation-Reduction; Reproducibility of Results; Tablets; Tandem Mass Spectrometry; Temperature; Tetrazoles | 2018 |
HPLC method transfer study for simultaneous determination of seven angiotensin II receptor blockers.
Topics: Acrylates; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Chlorthalidone; Chromatography, High Pressure Liquid; Hydrochlorothiazide; Imidazoles; Irbesartan; Losartan; Molecular Structure; Software; Tablets; Tetrazoles; Thiophenes; Valsartan | 2020 |